Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cytomegalovirus and immunomodulation].

B Charpentier1

  • 1Service de Néphrologie, Hôpital de Bicêtre, Kremlin-Bicêtre.

Nephrologie
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Cytomegalovirus (CMV) interacts closely with the immune system, impacting organ transplant patients. Understanding CMV

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COVID-19 epidemic phases: Criteria, challenges and issues for the future.

Bulletin de l'Academie nationale de medecine·2020
Same author

[Covid-19 epidemic phases: Criteria, challenges and issues for the future].

Bulletin de l'Academie nationale de medecine·2020
Same author

Efficacy of Prolonged- and Immediate-release Tacrolimus in Kidney Transplantation: A Pooled Analysis of Two Large, Randomized, Controlled Trials.

Transplantation proceedings·2017
Same author

Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Articulating the value of health research.

QJM : monthly journal of the Association of Physicians·2014
Same journal

Short-term effect of folic acid supplementation in renal transplant recipients and chronic kidney disease patients with comparable renal function impairment.

Nephrologie·2004
Same journal

[Acute renal failure and 2,8-dihydroxyadeninuria].

Nephrologie·2004
Same journal

[Phototherapy and hemodialysis pruritus].

Nephrologie·2004
Same journal

[Pregnancy and hemodialysis].

Nephrologie·2004
Same journal

[Role of dietary fibers in the nutritional management of chronic renal failure].

Nephrologie·2004
Same journal

[Abstracts of the VI Meeting of the Society of Nephrology and of the Francophone Society of Dialysis. Marseille, France, 28 September-1 October 2004].

Nephrologie·2004
See all related articles

Area of Science:

  • Immunology
  • Virology
  • Transplantation Science

Background:

  • Cytomegalovirus (CMV) establishes lifelong infections with latency and reactivation phases.
  • Cellular immunity is crucial for controlling CMV, with mechanisms including NK cells and cytotoxic T lymphocytes.
  • CMV infection and cellular rejection are interconnected, often exacerbating each other in transplant recipients.

Purpose of the Study:

  • To elucidate the intricate relationship between Cytomegalovirus and the host immune system.
  • To highlight the role of cellular immunity in managing CMV infections, particularly in immunocompromised individuals.
  • To explore the link between CMV infection, immunosuppression, and cellular rejection in organ transplantation.

Main Methods:

  • Review of immunological defense mechanisms against CMV.

Related Experiment Videos

  • Analysis of factors influencing CMV infection severity in organ transplant patients.
  • Examination of the interplay between CMV and cellular rejection processes.

    • Main Results:

    • CMV exhibits latency, reactivation, and transforming effects, underscoring the importance of cellular immunity.
    • Immunosuppression in organ transplantation significantly increases CMV infection frequency and severity.
    • A bidirectional relationship exists between CMV infection and cellular rejection, each potentially inducing the other.
    • Natural killer (NK) cells, cytotoxic T lymphocytes, and antibody-dependent cell cytotoxicity are key lytic mechanisms against CMV.

    Conclusions:

    • Cellular immunity plays a vital role in controlling Cytomegalovirus infections.
    • Organ transplantation contexts, particularly immunosuppression, heighten risks associated with CMV.
    • The complex interplay between CMV and cellular rejection necessitates careful management in transplant recipients.
    • CMV's transforming potential suggests a possible link to conditions like Kaposi sarcoma.